Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination | |||
---|---|---|---|
분류 | GMP, Guidance | 조회 | 3314 |
발행년도 | 2013 | 등록일 | 2015-10-02 |
출처 | FDA (바로가기) | ||
This guidance describes the importance of implementing manufacturing controls to prevent cross-contamination of finished pharmaceuticals and active pharmaceutical ingredients (APIs) with non-penicillin beta-lactam drugs.
(후략)
|
|
이전글 | Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography |
---|---|
다음글 | Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers |